191 related articles for article (PubMed ID: 34626498)
1. Age-specific burden of cervical cancer associated with HIV: A global analysis with a focus on sub-Saharan Africa.
Ibrahim Khalil A; Mpunga T; Wei F; Baussano I; de Martel C; Bray F; Stelzle D; Dryden-Peterson S; Jaquet A; Horner MJ; Awolude OA; Trejo MJ; Mudini W; Soliman AS; Sengayi-Muchengeti M; Coghill AE; van Aardt MC; De Vuyst H; Hawes SE; Broutet N; Dalal S; Clifford GM
Int J Cancer; 2022 Mar; 150(5):761-772. PubMed ID: 34626498
[TBL] [Abstract][Full Text] [Related]
2. Estimates of the global burden of cervical cancer associated with HIV.
Stelzle D; Tanaka LF; Lee KK; Ibrahim Khalil A; Baussano I; Shah ASV; McAllister DA; Gottlieb SL; Klug SJ; Winkler AS; Bray F; Baggaley R; Clifford GM; Broutet N; Dalal S
Lancet Glob Health; 2021 Feb; 9(2):e161-e169. PubMed ID: 33212031
[TBL] [Abstract][Full Text] [Related]
3. The burden of human papillomavirus infections and related diseases in sub-saharan Africa.
De Vuyst H; Alemany L; Lacey C; Chibwesha CJ; Sahasrabuddhe V; Banura C; Denny L; Parham GP
Vaccine; 2013 Dec; 31 Suppl 5(0 5):F32-46. PubMed ID: 24331746
[TBL] [Abstract][Full Text] [Related]
4. Regional and country-level trends in cervical cancer screening coverage in sub-Saharan Africa: A systematic analysis of population-based surveys (2000-2020).
Yang L; Boily MC; Rönn MM; Obiri-Yeboah D; Morhason-Bello I; Meda N; Lompo O; Mayaud P; Pickles M; Brisson M; Hodgins C; Delany-Moretlwe S; Maheu-Giroux M
PLoS Med; 2023 Jan; 20(1):e1004143. PubMed ID: 36634119
[TBL] [Abstract][Full Text] [Related]
5. Population risk factors for late-stage presentation of cervical cancer in sub-Saharan Africa.
Stewart TS; Moodley J; Walter FM
Cancer Epidemiol; 2018 Apr; 53():81-92. PubMed ID: 29414636
[TBL] [Abstract][Full Text] [Related]
6. Estimating the effect of HIV on cervical cancer elimination in South Africa: Comparative modelling of the impact of vaccination and screening.
Boily MC; Barnabas RV; Rönn MM; Bayer CJ; van Schalkwyk C; Soni N; Rao DW; Staadegaard L; Liu G; Silhol R; Brisson M; Johnson LF; Bloem P; Gottlieb S; Broutet N; Dalal S
EClinicalMedicine; 2022 Dec; 54():101754. PubMed ID: 36583170
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer in sub-Saharan Africa: an urgent call for improving accessibility and use of preventive services.
Dzinamarira T; Moyo E; Dzobo M; Mbunge E; Murewanhema G
Int J Gynecol Cancer; 2023 Apr; 33(4):592-597. PubMed ID: 36368710
[TBL] [Abstract][Full Text] [Related]
8. How the Cervical Microbiota Contributes to Cervical Cancer Risk in Sub-Saharan Africa.
Klein C; Kahesa C; Mwaiselage J; West JT; Wood C; Angeletti PC
Front Cell Infect Microbiol; 2020; 10():23. PubMed ID: 32117800
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer prevention in countries with the highest HIV prevalence: a review of policies.
Asangbeh-Kerman SL; Davidović M; Taghavi K; Kachingwe J; Rammipi KM; Muzingwani L; Pascoe M; Jousse M; Mulongo M; Mwanahamuntu M; Tapela N; Akintade O; Basu P; Dlamini X; Bohlius J
BMC Public Health; 2022 Aug; 22(1):1530. PubMed ID: 35948944
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus distribution in invasive cervical carcinoma in sub-Saharan Africa: could HIV explain the differences?
Ndiaye C; Alemany L; Ndiaye N; Kamaté B; Diop Y; Odida M; Banjo K; Tous S; Klaustermeier JE; Clavero O; Castellsagué X; Bosch FX; Trottier H; de Sanjosé S
Trop Med Int Health; 2012 Dec; 17(12):1432-40. PubMed ID: 23107344
[TBL] [Abstract][Full Text] [Related]
11. Burden of Kaposi sarcoma according to HIV status: A systematic review and global analysis.
Ibrahim Khalil A; Franceschi S; de Martel C; Bray F; Clifford GM
Int J Cancer; 2022 Jun; 150(12):1948-1957. PubMed ID: 35085400
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review.
Louie KS; de Sanjose S; Mayaud P
Trop Med Int Health; 2009 Oct; 14(10):1287-302. PubMed ID: 19772550
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer in sub-Saharan Africa: a preventable noncommunicable disease.
Mboumba Bouassa RS; Prazuck T; Lethu T; Jenabian MA; Meye JF; Bélec L
Expert Rev Anti Infect Ther; 2017 Jun; 15(6):613-627. PubMed ID: 28440679
[TBL] [Abstract][Full Text] [Related]
14. Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control.
Hall MT; Smith MA; Simms KT; Barnabas R; Murray JM; Canfell K
Int J Cancer; 2021 Jul; 149(2):297-306. PubMed ID: 33634857
[TBL] [Abstract][Full Text] [Related]
15. Global and regional estimates of cervical cancer burden associated with human immunodeficiency virus infection from 1990 to 2019.
Wan Z; Zhao J; Xu L; Sun P; Shuai P; Li K; Zhang Y; Chen Y; Su Q; Yao X; Li X; Liu Y
J Med Virol; 2023 Jun; 95(6):e28891. PubMed ID: 37338085
[TBL] [Abstract][Full Text] [Related]
16. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
18. Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs.
Bray F; Parkin DM;
Lancet Oncol; 2022 Jun; 23(6):719-728. PubMed ID: 35550275
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa.
ter Meulen J; Eberhardt HC; Luande J; Mgaya HN; Chang-Claude J; Mtiro H; Mhina M; Kashaija P; Ockert S; Yu X
Int J Cancer; 1992 Jun; 51(4):515-21. PubMed ID: 1318265
[TBL] [Abstract][Full Text] [Related]
20. Global burden of human papillomavirus and related diseases.
Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]